Ypsomed
Update in progressYPSN.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Instruments & Supplies
Ypsomed Holding AG and its subsidiaries design, manufacture, and sell injection and infusion systems for safer, simpler self-medication. It operates three segments: Delivery Systems, Diabetes Care, and Others. Delivery Systems offers pen injectors, auto-injectors, wearable injectors, and smart devices under the YDS brand. Diabetes Care sells insulin pumps, infusion sets, needles, glucose monitoring, and related items under mylife. It also provides precision parts and contract manufacturing. Markets through pharma partners, its own network, and distributors. Headquartered in Burgdorf, Switzerland, founded in 1984, with activities in Europe, North America, and globally.
Company score
- Sentiment
- 0.30
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.06
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.22
- Governance
- 0.09
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.18
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!